Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 22 Show results per page	View Search Criteria \| Help With Results


1.		Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				30 and over								PVSG-10

Last Modified: 7/1/1991


2.		Phase I/II Study of FLAP (5-FU/LV/AZT/DP) in Patients with Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				BRMP-8916C NCI-90-C-45C, NCI-T89-0135N, T89-0135

Last Modified: 8/1/1991


3.		Phase I/II Study of 14-Day Continuous Infusions of 5-FU/CF with Oral DP in Patients with Advanced Gastrointestinal and Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				20 to 80								TCC-5290 NCI-V91-0020

Last Modified: 5/2/2007 First Published: 7/1/1997


4.		Phase II Study of Fluorouracil, Leucovorin, Mitomycin and Dipyridamole in Patients with Locally Advanced Unresected Pancreatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Not specified				NCI				SWOG-S9700 NCT00003018, S9700


5.		Phase II Chemotherapy with MTX/DP in the Treatment of Patients with Metastatic, Locally Recurrent, or Unresectable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								NYU-8505 NCI-V86-0002


6.		Phase II Chemotherapy with DP/MTX/HU/ARA-C in Patients with Advanced Hodgkin's Disease or non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								MRH-860207 UCCRC-4586, NCI-V86-0102


7.		Phase II Study of Chemotherapy with PALA plus Dipyridamole (Persantine) in Patients with Advanced Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-876 NCI-T86-0200D, T86-0200

Last Modified: 10/1/1988


8.		Phase II Chemotherapy with PALA plus Oral Dipyridamole in Patients with Metastatic non-Small Cell Lung Cancer (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				PURDUE-T87-0046 NCI-T87-0046D, T87-0046

Last Modified: 2/1/1989


9.		Phase II Chemotherapy with 5-FU with Biochemical Modulation with Folinic Acid and Dipyridamole in Patients with Advanced Prostate Cancer (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				any age								CHNMC-IRB-7082 NCI-V88-0541

Last Modified: 4/26/2007


10.		Phase II Study of VBL/Dipyridamole in Patients with Locally Unresectable or Metastatic Renal Cell Adenocarcinoma (Summary Last Modified 12/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								HOG-GU88-1 NCI-V89-0242

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute